ARTICLE / CLIENT ALERT
Colorado Finalizes Sweeping New Privacy Rules; Iowa Joins the Fray
March 21, 2023
Read time: 5 min
There has been a flurry of state privacy activity in the past week, with Colorado becoming the latest state to finalize sweeping data privacy rules and Iowa on the precipice of becoming the sixth state to enact comprehensive privacy legislation. Read this article to learn more about how the new Colorado rules go beyond existing California and Virginia laws, as well as how Iowa stacks up against the five other existing state laws.
COLORADO ATTORNEY GENERAL FINALIZES CPA REGULATIONS
On March 15, 2023, the Colorado Attorney General’s Office filed the final Colorado Privacy Act rules (together with the underlying Colorado Privacy Act, the Colorado Rules) for publication in the Colorado Register, which will take effect on July 1, 2023. Although the Colorado Rules largely mirror California and Virginia requirements, numerous new obligations go beyond existing law that will require companies to update their compliance programs, including:
- Additional requirements for deletion requests: Controllers who deny requests to delete must describe the types of data collected from third parties that the company did not delete (this requirement does not apply to data collected directly from the individual).
- Flow down all data subject rights to processors: Controllers must flow down all data subject requests that controllers honor to processors, including requests to opt out of targeted advertising and sales of personal data. The California and Virginia rules, by contrast, only require flowing down certain requests in limited circumstances.
- Honor more specific opt-out technologies: California and Colorado both require controllers to honor opt-out preference signals, but Colorado will go further and publish a specific list of universal opt-out mechanisms by January 1, 2024, which will be updated over time. Controllers must honor the specified signals within six months of publication.
- Detailed privacy notice requirements: Controllers must specify in their privacy notices the express purpose for which each category of personal data is used. Privacy notices must also specify which data subject rights are available to Colorado residents.
- Granular data protection assessment requirements: Like California and Virginia, the Colorado Rules require controllers to conduct “data protection assessments” when engaging in “higher risk” processing activities, such as processing sensitive data or engaging in selling/targeted advertising. However, unlike California (which has yet to enact regulations) and Virginia (which has limited details), the Colorado Rules require such assessments to include extensive content, including:
- The nature and operational elements of the processing activity
- The sources of personal data
- The technology or processors to be used
- The names and categories of the personal data recipients
- Operational details about the processing
- The core purposes of the processing activity
- The sources and nature of risks to the rights of consumers
- Measures and safeguards in place to protect consumers
- A description of how the benefits of processing outweigh the identified risks.
The Colorado Rules also provide detailed examples showing how to analyze each factor.
- Detailed consent requirements: The Colorado Rules impose heightened consent requirements, such as when processing sensitive data and making inferences about sensitive characteristics using non-sensitive data. Although consent to process sensitive data is currently required in Virginia, the Colorado Rules add additional granularity and guidance on obtaining such consent.
- Applicability to nonprofits: Unlike all the other state privacy laws, the Colorado Rules apply to nonprofits that engage in “commercial activity.”
IOWA POISED TO BECOME SIXTH STATE TO ENACT A CONSUMER PRIVACY LAW
Also on March 15, 2023, Iowa’s legislature unanimously passed Senate File 262 (S.F. 262), making it the sixth US state consumer privacy law once the governor signs the bill into law. The bill closely resembles the Utah Privacy Act, which followed the model set by Virginia, Colorado and Connecticut while loosening or omitting several key provisions. Similar to jurisdictional triggers in other states (except California), the Iowa law would apply to businesses that control or process personal data on 100,000 Iowan consumers or derive 50% of revenue from selling the data of more than 25,000 Iowan consumers. The law contains similar notice, access, deletion, contracting and enforcement provisions as the laws in these other states. However, like Utah’s law, the Iowa bill:
- Imposes a right to opt out, not opt in, for the processing of “sensitive data”
- Omits any right to “correct” inaccurate information or to opt out of certain automated “profiling.”
The bill, which will take effect January 1, 2025, if enacted, should not create significant new compliance hurdles for most businesses beyond what is already required under existing US state privacy laws. Businesses should nevertheless ensure they closely review the impending Iowa law and incorporate it into their existing privacy programs.
CONCLUSION
This year has been off to a busy start with new laws taking effect in California and Virginia, California and Colorado finalizing regulations (both of which will require businesses to materially update their compliance programs) and Iowa jumping into the fray. We can expect to see the US state privacy landscape continue to grow increasingly complex as other states introduce new privacy legislation and move this momentum forward. Companies looking for help navigating these complex rules and practical, risk-based compliance recommendations should reach out to one of the authors of this article or your regular McDermott contact.

Preparing for the End of the COVID-19 Emergency: Telehealth
ARTICLE / CLIENT ALERT
Preparing for the End of the COVID-19 Emergency: Telehealth
March 21, 2023
Read time: 4 min
Our April 3, 2023, webinar explored the impacts that the end of the PHE and NE will have on employee benefit plans and what actions employers and benefit plan sponsors should be taking to prepare. Watch the “How Employers Should Prepare for the End of the Covid-19 National and Public Health Emergencies” webinar recording to learn more.
The Biden administration has announced its intent to end the COVID-19 National Emergency (NE) and the COVID-19 Public Health Emergency (PHE) on May 11, 2023 (read our client alert, “Preparing for the End of the COVID-19 Emergency: Coverage of COVID-19 Vaccines,” for more information). In response to the COVID-19 pandemic, lawmakers and agencies made legislative and regulatory changes to expand access to telehealth services for individuals. This article explores what will happen to these temporary telehealth benefits at the end of the PHE and NE.
TELEHEALTH BENEFIT OFFERINGS
Current flexibilities under the Affordable Care Act (ACA) allow applicable large employers (ALEs) to offer stand-alone telehealth and remote care services to employees who were not eligible for other employer coverage during the PHE.
In addition, the Coronavirus Aid, Relief, and Economic Security Act (CARES) Act and IRS Notice 2020-29 established a temporary telehealth safe harbor, providing that a high-deductible health plan (HDHP) could cover telehealth and other remote care services on a pre-deductible basis without impacting an individual’s ability to contribute to an HSA. This relief applied to services provided on or after January 1, 2020, with respect to plan years beginning on or before December 31, 2021. Thus, for most calendar-year plans, this relief ended on December 31, 2021. The Consolidated Appropriations Act, 2022 (CAA 2022) renewed the relief under the CARES Act for months beginning after March 31, 2022, and before January 1, 2023—but it created a three-month gap in coverage from January 1, 2022, to March 31, 2022. The CAA 2022 also extended certain flexibilities related to Medicare coverage and payment for telehealth services through the end of 2024. The relief provided under the CAA 2022, however, was provided on a temporary basis and not tied to the PHE or NE.
Effective December 29, 2022, the Consolidated Appropriations Act, 2023 (CAA 2023) provided a two-year extension allowing first-dollar coverage of telehealth under an HDHP so that individuals can access services without needing to meet a deductible first. The CAA 2023 extends telehealth relief for plan years beginning after December 31, 2022, and before January 1, 2025. Most calendar year plans should therefore have coverage of pre-deductible telehealth services without affecting HSA eligibility for all of 2023 and 2024. When the PHE ends, stand-alone telehealth offerings must cease, but telehealth offerings on a pre-deductible basis can continue.
ACTION ITEMS
The stand-alone telehealth relief under the ACA is available until the end of the latest plan year that begins on or before the last day of the PHE. For calendar-year plans, this relief would last until December 31, 2023. When an employer ends its stand-alone telehealth benefit, it may need to provide participants a 60-day notice of a material reduction in benefits.
Employers offering telehealth coverage on a pre-deductible basis with HDHPs have been provided statutory relief through December 31, 2024, through the CAA 2023. However, employers should continue to watch for legislative updates regarding telehealth. Lawmakers have proposed multiple other bills in Congress to extend or make permanent telehealth flexibilities.
For any questions regarding the end of the PHE and/or NE, please contact your regular McDermott lawyer or one of the authors.

Digital Health Laws & Regulations 2023: Germany
ARTICLE
Digital Health Laws & Regulations 2023: Germany
March 2023
Read time: 2 min
ICLG’s unmissable, comprehensive guide to the field of Digital Health contains everything you need to know about digital health and healthcare, including regulatory issues, data use, data sharing, health technology, health IP, commercial agreements and AI & machine learning.
Our German healthcare team contributed the Germany chapter of the guide, which covers everything businesses should know to place themselves strategically within the sector, and look ahead to burgeoning opportunities.

2023 Annual Health Report | Managed Care 2022 Year in Review
ARTICLE / REPORT
2023 Annual Health Report | Managed Care 2022 Year in Review
March 2023
Read time: 2 min
The managed care space saw a number of regulatory and legislative developments in 2022 that are shaping the sector as we move further into 2023. Against this backdrop, the healthcare industry itself has continued to transform in response to the demand for improved patient care at lower costs, heightened focus on health equity, and other social and economic issues.
Our managed care team reviews updates across core managed care issues and delivers an overview of market trends, including:
- M&A Trends
- State of Health System-Plan Joint Ventures
- Risk Adjustment Data Validation (RADV) rule developments and other regulatory and legislative activity
- Medicare Advantage Scrutiny
- CMMI Models
- ERISA Preemption Developments
The authors wish to thank Mara McDermott for her contributions to this report.
2023 Annual Health Report | Healthcare Private Equity
ARTICLE / REPORT
2023 Annual Health Report | Healthcare Private Equity
March 2023
Read time: 2 min
Private equity investment in healthcare reached an all-time high in 2022, with reports putting the overall deal value at a staggering $151 billion. But 2023 is shaping up to be a very different year, with investors pulling back as they try to figure out how long the landscape will be dominated by rising labor costs and interest rates. Here are five trends to watch in private equity healthcare investing from our conversations with leading investors and bankers.
This special report was originally released through The Deal.

Recent Developments in Tax Law: New Developments in the Taxation of Photovoltaic Systems
ARTICLE
Recent Developments in Tax Law: New Developments in the Taxation of Photovoltaic Systems
March 8, 2023
Read time: 2 min
Dr. Gero Burwitz and Jonathan Storz authored the article “New developments in the taxation of photovoltaic systems”, featured in Neue Zeitschrift für Gesellschaftsrecht (NZG), p. 297 et seq. in March, 2023.

Proposed Changes to DSH Payment Calculation Regulations Could Impact 340B Hospitals
ARTICLE / CLIENT ALERT
Proposed Changes to DSH Payment Calculation Regulations Could Impact 340B Hospitals
March 10, 2023
Read time: 4 min
On February 28, 2023, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule that would change how Medicare disproportionate share hospital (DSH) payments are calculated with respect to the counting of days associated with Section 1115 demonstrations in the Medicaid fraction of the DSH calculation. This proposed rule is a follow-up to the FY 2022 and FY 2023 Inpatient Prospective Payment System (IPPS) proposed rules, which initially included similar proposed revisions to the treatment of certain Section 1115 waiver days for purposes of the Medicare DSH adjustment.
The proposed change would effectively reduce the number of patient days that are utilized in the DSH payment calculation. CMS previously proposed similar modifications to regulations related to the calculation of the Medicare DSH adjustment in response to a series of court cases that interpreted the current regulatory language as requiring CMS to count patient days associated with CMS-approved Section 1115 demonstration projects for uncompensated care pools and patient premium assistance programs in the Medicaid DSH calculation. This interpretation has essentially permitted hospitals in certain states, pursuant to these court rulings, to count patient days associated with approved Section 1115 waiver programs on the hospital’s cost reports for purposes of the Medicare DSH adjustment.
Under the most recent proposal, CMS would define patients who are “regarded as eligible” for Medicaid to include only certain patients who receive health insurance or premium assistance that meets certain additional requirements under a Section 1115 waiver. For purposes of the Medicare DSH calculations, CMS proposes to include in the fraction only those patients who receive health insurance or buy health insurance with premium assistance provided under a Section 1115 demonstration where states receive matching funds for such programs. The patient days proposed to be included in the Medicaid fraction numerator would include only patient days associated with patients covered under a Section 1115 demonstration who receive health insurance that covers inpatient hospital services or receive premium assistance that covers 100% of the patient’s premium cost that includes coverage for inpatient services. This is a change from the most recent CMS proposal in the IPPS FY 2023 proposed rule, which would have permitted the inclusion of patient days associated with patients who receive premium assistance covering 90% of the patient’s premium cost.
CMS also proposes to clarify its interpretation that patient days associated with care funded through a Section 1115 demonstration uncompensated care pool are not viewed as patient days for patients who are “regarded as” Medicaid-eligible. Therefore, hospitals in Florida, Kansas, Massachusetts, New Mexico, Tennessee and Texas would no longer be permitted to report patient days in the DSH calculation associated with payments from these states’ Section 1115 demonstration projects for uncompensated or undercompensated care pools. CMS estimates that this change would result in a decrease of approximately $345 million in DSH funding across these states.
Based on the proposed rule language, CMS appears to be sending a signal to states that have not expanded Medicaid. This proposal would negatively impact hospitals in non-expansion states that utilize uncompensated care pools and premium assistance programs through 1115 waivers. In addition to decreasing the amounts paid by Medicare to these hospitals, the proposed change in counting patient days could cause hospitals that participate in the 340B Program to lose their program eligibility because of the decreased DSH adjustment percentage. Some hospitals in affected states also would face a decrease in DSH adjustments, which likely would have negative financial implications on these facilities.
This proposal, if finalized, would limit the types of Section 1115 waiver days that can be included in the Medicaid fraction of the DSH adjustment. CMS proposes that the regulation would be effective for patient discharges occurring on or after October 1, 2023. Comments on the proposed rule are due May 1, 2023.

HPE Miami 2023 | Buyer Beware: The Importance of Due Diligence in Healthcare Transactions
ARTICLE
HPE Miami 2023 | Buyer Beware: The Importance of Due Diligence in Healthcare Transactions
March 8-9, 2023
Read time: 3 min
In this session, McDermott partners Matt Friendly and Ann Marie Brodarick moderated a panel discussion highlighting current considerations for buyers conducting legal and financial due diligence in healthcare M&A.
This session featured insights from the following panelists:
- Philip Pfrang, Partner, Deloitte
- Monica Wallace, Partner, McDermott Will & Emery
Key takeaways included:
- Data processing speed has removed significant roadblocks for acquirers examining healthcare targets. There is no excuse to overlook billing practices, risk factor adjustments and estimation risk when evaluating targets.
- Lawyers and accountants should collaborate to ensure that revenue at healthcare targets is clean from a regulatory perspective. The large amount of government dollars poured into the healthcare sector in recent years makes it ripe for regulatory scrutiny.
- Some of the main healthcare regulatory risks facing healthcare targets include fraud and abuse compliance which takes into account state and federal self-referral, kickback and false claims laws; license, CON and corporate practice HIPAA; COVID waivers/flexibilities compliance and upcoming end of the public health emergency; and proper use of COVID-19 government funding.
- From a financial diligence and tax perspective, it is critical to align on the tax structure of a deal before reaching a finalized letter of intent.
- Instead of siloing specialists, buyers should encourage lawyers, accountants, tax advisors and healthcare-specific advisors to collaborate—for example, by conducting group calls among the various diligence providers.
- Human relations and a healthcare target’s ability to attract and retain top talent has become a primary issue in healthcare diligence.

HPE Miami 2023 | The Next Generation of PE and Hospital & Health System Collaboration
ARTICLE
HPE Miami 2023 | The Next Generation of PE and Hospital & Health System Collaboration
March 8-9, 2023
Read time: 2 min
During this session, Partners Charlie Buck and Megan Rooney moderated a roundtable discussion on how and why partnerships between private equity and health systems develop and evolve and what the future holds for these creative deal structures.
Session panelists included:
- Bede Broome, MD, PhD, Managing Director, Assured Healthcare Partners
- Jared Langus, Partner, ECG Management Consultants
- Ian Spier, Senior Vice President, Novant Health Enterprises
Key takeaways included:
- While it is a frequent topic of discussion, collaborations between health systems and private equity have been limited. However, headwinds in the health system sector might change that in the coming years. Significant potential for collaboration exists with respect to outsourcing nonclinical operations, service line joint ventures, physician platform collaborations and ambulatory surgery centers.
- Access to capital is not always the key driver for health systems that seek “partners.” In addition to capital, private equity collaborations often offer operational expertise and experience with respect to growth and scaling. From the perspective of health systems, business-building acumen is often what differentiates private equity partners.
- Private equity groups look to collaborate with health systems that are aligned with their incentives and goals and are open, forward-thinking and concerned with the overall cost of care.

HPE Miami 2023 | Revolutionizing Healthcare with Value-Based Care
ARTICLE
HPE Miami 2023 | Revolutionizing Healthcare with Value-Based Care
March 8-9, 2023
Read time: 4 min
During this session, Samarth Chandra, Kunal Kain, John Smith and Partners Jeremy Earl and Kate McDonald moderated a panel that examined the current market for value-based care companies and how investors can identify value-based care companies that will succeed over the long term. The panel also discussed how value-based care is evolving as the market becomes increasingly sophisticated and more companies adopt risk-based and other value-based payment models.
Session panelists included:
- Samarth Chandra, General Partner, Enhanced Healthcare Partners
- Kunal Kain, Managing Partner, Kain Capital
- John Smith, Principal, Leavitt Equity Partners
- Jeremy Earl, Partner, McDermott Will & Emery (Moderator)
- Kate McDonald, Partner, McDermott Will & Emery (Moderator)
Key takeaways included:
- The conversation highlighted the value of technology in controlling costs and improving patient outcomes as the market shifts toward a value-based care model. Building systems that invoke technology and data can enable physicians to spend more time with patients, thereby improving patient health outcomes and preventing informational asymmetries between primary care doctors and specialist groups. Furthermore, adding point of care solutions within physicians’ workflows allows them to make better clinical decisions for their patients and acts as a cost-curbing mechanism. As technology adoption increases over time, it can be leveraged to prevent leakage because doctors will have more tools to be proactive and preventative in administering treatment.
- Value-based care models may also be better equipped to handle a rapidly growing senior population. With more than 65 million seniors in the United States today, the federal government will need to be sophisticated when deciding how to shape the system to promote beneficial health outcomes. Given that the Medicare Part A fund is anticipated to be insolvent by 2028, creative Medicare programs (e.g., the ACO Realizing Equity, Access, and Community Health (REACH) model) provide the opportunity to spur innovation and address the overall change in patient demographics. However, there is also a risk associated with chasing the economic opportunity associated with shifting care populations and these nascent delivery models.
- One hurdle blocking the implementation of value-based care models is whether payors are prepared for the shift from a fee-for-service-based model. Collaboration will be necessary to address the social issues (i.e., improving healthcare outcomes for an aging and generally unhealthier care population) underlying the shift to value-based care. This includes partnering with cost-effective, nonclinical resources to address social determinants of health (e.g., not having a meal or transportation to appointments), which will in turn create leverage for clinical resources to triage cases in a more appropriate way.
- Investors will also need to be mindful of the capital requirements represented by different models of care (e.g., clinical ownership, wraparound/affiliate). The wraparound model does not require intensive capital expenditures; however, it can take longer to implement with respect to certain services and does not offer the benefit of acting as a full cultural change within the practice group. In the current market where cost of capital is higher, this may not be as important. The clinical ownership model is far more capital-intensive but also provides the requisite level of control necessary to manage practice innovation and eventual cost savings. While value-based care investments are currently targeted toward primary care providers, there are specialties, such as oncology, cardiology, orthopedic, kidney care and ophthalmology, that represent well-positioned investment opportunities.
